The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.

Newsletter Jan 2017

Latest Newsletter with the new members of the Scientific Advisory Committee, the public World RePort data base with funding data from NIH, MRC UK, SIDA, EDCTP and other funders and the Ditect-HAT project on diagnostics for sleeping sickness.

Read more

Eighth EDCTP Forum

We published the highlights of the Eighth EDCTP Forum in Lusaka, Zambia from 6-9 November 2016

Forum abstracts were published in BMJ Global Health







Read more

Call for Experts

Extended till 28 February 2017! Call for Experts in the fields of ‘Implementation research’ or ‘biomedical ethics’ for the Scientific Advisory Committee. This Committtee advises EDCTP on strategy. It is not involved in the review EDCTP calls for proposals.


Read more

Latest news

16 February 2017

PredART trial: prednisone reduces risk of TB-IRIS in HIV-infected patients by 30%

Results of the EDCTP-funded PredART clinical trial, led by Dr Graeme Meintjes, University of Cape Town, South Africa were presented…

Read more
17 January 2017

Switzerland fully associated to Horizon 2020 per 1 January 2017

Switzerland became an Associated Country for the full Horizon 2020 programme as of 1 January 2017. Consequently, Switzerland has regained the possibility…

Read more